狼疮相关PNP基因功能性多态性导致人免疫细胞周期异常与干扰素通路激活
本研究对SLE相关的PNP基因错义SNP rs1049564进行功能验证,发现TT基因型淋巴母细胞样细胞中PNP mRNA和蛋白水平降低、酶活性下降,S期阻滞约为CC型的2倍,且I型干扰素诱导转录本随T等位基因剂量增加而升高。S期阻滞可被次黄嘌呤和腺苷药理学逆转,提示PNP相对缺陷是其原因。
要点
- PNP rs1049564 T等位基因是功能丧失性变异,降低PNP表达与酶活性。
- TT基因型细胞S期阻滞较CC型增加2倍,可被次黄嘌呤和腺苷逆转。
- I型干扰素诱导转录本随T等位基因呈剂量反应性升高,基线及刺激后均如此。
核心结论
- PNP rs1049564 T等位基因是功能丧失性变异,在淋巴细胞中诱导S期阻滞和干扰素通路激活。
研究设计与样本
- 研究在已知PNP rs1049564基因型的人淋巴母细胞样细胞系中检测PNP mRNA、蛋白、酶活性、I型干扰素诱导基因表达及细胞周期,并用PyMOL进行结构建模。
- 患者血清I型干扰素采用报告细胞试验检测。
主要发现
- 结构建模未显示rs1049564导致主要折叠破坏。
- 纯合rs1049564 TT淋巴母细胞样细胞PNP mRNA表达和蛋白水平降低,且在控制PNP量时酶活性仍降低。
- TT基因型细胞S期阻滞较纯合CC表型增加2倍。
- S期阻滞可被次黄嘌呤和腺苷药理学逆转,支持相对PNP缺陷是其原因。
- I型干扰素诱导转录本在基线和I型干扰素刺激后均随rs1049564 T等位基因呈剂量反应性增加。
关键数值与推荐
- TT基因型细胞S期阻滞较CC型增加2倍。
- I型干扰素诱导转录本随T等位基因呈剂量反应性增加,见于基线和I型干扰素刺激后。
临床怎么用
- PNP rs1049564 T等位基因可能作为SLE中I型干扰素通路激活的功能性标记。
- 体外S期阻滞可被次黄嘌呤和腺苷逆转,提示潜在个性化治疗方向。
局限性
- 功能验证主要在淋巴母细胞样细胞系中进行,尚未在原代细胞或临床样本中广泛验证。
- 结构建模未显示主要折叠破坏,机制细节仍需进一步阐明。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Systemic lupus erythematosus (SLE) is frequently characterized by activation of the type I interferon (IFN) pathway. We previously observed that a missense single-nucleotide polymorphism (rs1049564) in the purine nucleoside phosphorylase (PNP) gene was associated with high levels of IFN in SLE. PNP is a key enzyme involved in purine metabolism. In this study, we performed functional follow-up of this polymorphism in human cells. METHODS: Type I IFN was measured in patient sera, using a reporter cell assay. Structural modeling of the PNP variant was performed using PyMOL software. PNP messenger RNA (mRNA) and protein levels and type I IFN-induced gene expression were measured in lymphoblastoid cell lines with known PNP rs1049564 genotypes. The cell cycle was assayed using flow cytometry. RESULTS: Structural modeling indicated no major disruption in folding related to rs1049564. We observed that homozygous rs1049564 TT lymphoblastoid cells had decreased PNP mRNA expression and protein levels, and that cells with the TT genotype had reduced PNP enzymatic activity even when the amount of PNP was controlled. Cells with the TT genotype had a 2-fold increase in S-phase block as compared with cells with the homozygous CC phenotype. The S-phase block could be pharmacologically reversed with hypoxanthine and adenosine, supporting the notion that relative PNP deficiency is the cause of the S-phase block. Type I IFN-induced transcripts were increased in a dose-response manner related to the rs1049564 T allele, at both baseline and after type I IFN stimulation. CONCLUSION: The PNP rs1049564 T allele is a loss-of-function variant that induces S-phase block and IFN pathway activation in lymphocytes. The S-phase block could be rescued in our in vitro experiments, suggesting the potential for personalized treatment.
引用
- Ghodke-Puranik Y, Dorschner JM, Vsetecka DM, et al. Lupus-Associated Functional Polymorphism in PNP Causes Cell Cycle Abnormalities and Interferon Pathway Activation in Human Immune Cells. Arthritis Rheumatol. 2017. PMID: 28859258. doi:10.1002/art.40304
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。